A new nano-based drug delivery technology could outwit tuberculosis (TB)—one of humanity's most ancient diseases.

A new compound called CMX410 may change the fight against tuberculosis. It targets a weak point in the bacteria’s defenses, ...

A team of researchers at the University of Witwatersrand are developing a system of medicine delivery at the nano scale to ...

NEW YORK – Danaher subsidiary Cepheid announced on Tuesday that its Xpert MTB/XDR test for tuberculosis drug resistance has been awarded prequalification status by the World Health Organization.

An elderly woman's x-ray revealed the bizarre treatment she received decades earlier to treat the world's deadliest disease, ...

A Hospital consultant was apologetic to the relatives of a woman who died from a toxic side-effect of a drug prescribed to treat her latent tuberculosis. At the inquest into the death of Dymphna Dykes ...

WHO’s guidelines: Nutrition as a core component of treatment Earlier this month, on October 8, WHO released new guidelines emphasizing the role of nutrition in TB care. Among the key recommendations, ...

Orphan designation is granted to drug candidates addressing life-threatening or chronically debilitating diseases affecting fewer than 5 in 10’000 EU residents EMA orphan status provides key ...

1 Fujian Center for Disease Control and Prevention, Fuzhou, China 2 Fujian Provincial Key Laboratory of Zoonosis Research, Fuzhou, China Backgrounds: Rifampicin-resistant tuberculosis (RR-TB) remains ...

TRUNCATE-TB was a multi-arm, multi-stage, open-label, randomised controlled trial in which participants aged 18–65 years with rifampicin-susceptible pulmonary tuberculosis were randomly assigned via a ...